Wendy Dangerfield

946 total citations
7 papers, 805 citations indexed

About

Wendy Dangerfield is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Wendy Dangerfield has authored 7 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Wendy Dangerfield's work include Cancer therapeutics and mechanisms (7 papers), Drug Transport and Resistance Mechanisms (3 papers) and Synthesis and biological activity (2 papers). Wendy Dangerfield is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Drug Transport and Resistance Mechanisms (3 papers) and Synthesis and biological activity (2 papers). Wendy Dangerfield collaborates with scholars based in New Zealand and United Kingdom. Wendy Dangerfield's co-authors include Peter Charlton, Prakash Mistry, Alistair Stewart, Chris Liddle, Douglas Bootle, Jane A. Plumb, David J. Templeton, William A. Denny, John Milton and Adrian Folkes and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Anti-Cancer Drugs.

In The Last Decade

Wendy Dangerfield

7 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy Dangerfield New Zealand	7	419	366	292	139	129	7	805
Ellen Friche Denmark	16	496 1.2×	500 1.4×	61 0.2×	53 0.4×	44 0.3×	28	733
Adrian Folkes United Kingdom	7	163 0.4×	207 0.6×	164 0.6×	54 0.4×	69 0.5×	11	438
Yu-Shan Wu Taiwan	10	185 0.4×	281 0.8×	199 0.7×	26 0.2×	79 0.6×	10	644
Vincent Galullo United States	10	182 0.4×	468 1.3×	229 0.8×	34 0.2×	63 0.5×	10	724
Gwan Sun Lee South Korea	13	238 0.6×	311 0.8×	204 0.7×	26 0.2×	18 0.1×	21	595
Kevin L. Law United States	11	233 0.6×	224 0.6×	99 0.3×	70 0.5×	63 0.5×	11	444
Shih-Fong Chen United States	14	110 0.3×	479 1.3×	129 0.4×	38 0.3×	132 1.0×	22	727
Xinhui Zhang China	16	224 0.5×	398 1.1×	271 0.9×	16 0.1×	62 0.5×	32	776
Szabolcs Modok United Kingdom	10	458 1.1×	323 0.9×	43 0.1×	93 0.7×	82 0.6×	11	683
Hyo-Kyung Han United States	9	177 0.4×	191 0.5×	59 0.2×	43 0.3×	75 0.6×	12	493

Countries citing papers authored by Wendy Dangerfield

Since Specialization

Citations

This map shows the geographic impact of Wendy Dangerfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Dangerfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Dangerfield more than expected).

Fields of papers citing papers by Wendy Dangerfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Dangerfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Dangerfield. The network helps show where Wendy Dangerfield may publish in the future.

Co-authorship network of co-authors of Wendy Dangerfield

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Dangerfield. A scholar is included among the top collaborators of Wendy Dangerfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Dangerfield. Wendy Dangerfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wang, Shouming, Hamish Ryder, Paul Depledge, et al.. (2002). Studies on Quinazolinones as Dual Inhibitors of Pgp and MRP1 in Multidrug Resistance. Bioorganic & Medicinal Chemistry Letters. 12(4). 571–574. 32 indexed citations

2.

Mistry, Prakash, Alistair Stewart, Wendy Dangerfield, et al.. (2002). In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II. Anti-Cancer Drugs. 13(1). 15–28. 50 indexed citations

3.

Vicker, Nigel, Irina Chuckowree, Adrian Folkes, et al.. (2002). Novel Angular Benzophenazines: Dual Topoisomerase I and Topoisomerase II Inhibitors as Potential Anticancer Agents. Journal of Medicinal Chemistry. 45(3). 721–739. 116 indexed citations

4.

Gamage, Swarna A., Julie A. Spicer, Gordon W. Rewcastle, et al.. (2002). Structure−Activity Relationships for Pyrido-, Imidazo-, Pyrazolo-, Pyrazino-, and Pyrrolophenazinecarboxamides as Topoisomerase-Targeted Anticancer Agents. Journal of Medicinal Chemistry. 45(3). 740–743. 126 indexed citations

5.

Stewart, Alistair, Prakash Mistry, Wendy Dangerfield, et al.. (2001). Antitumor activity of XR5944, a novel and potent topoisomerase poison. Anti-Cancer Drugs. 12(4). 359–367. 44 indexed citations

6.

Mistry, Prakash, Alistair Stewart, Wendy Dangerfield, et al.. (2001). In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.. PubMed. 61(2). 749–58. 302 indexed citations

7.

Roe, Michael W., Adrian Folkes, Philip J. Ashworth, et al.. (1999). Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. Bioorganic & Medicinal Chemistry Letters. 9(4). 595–600. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact